Diligence memo · auto-generated · as of July 2, 2026
23andMe, Inc.
23andMe, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
23andMe, Inc. operates in Other Technology, based in Sunnyvale. 23andMe is a saliva-based DNA service. We provide genetic reports on your ancestry, family history and help you connect with your DNA relatives.
Capital & rounds (filed)filed
23andMe, Inc. has raised $820M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $300M on 2018-07-24.
Most recent recorded round closed around 2020-12-09.
Valuation (modeled)modeled
Provath models 23andMe, Inc. at approximately $2.3B (range $458M–$4.9B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.62× the median modeled value of Series D+ Other Technology companies in 2019–2021 (105 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 18 months.
Last raise 5.6 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 3.6× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 100% of Other Technology peers (21302 compared).
Modeled value ranks above 98% of those peers.
Closest niche peers: Dataminr, Inc., 2U, Inc., KnowBe4, Inc., Automation Anywhere, Inc., Courier Plus, Inc..
Peoplefiled
17 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.